Cell therapy manufacturing must account for biological variability while consistently delivering products with defined cellular composition and functional performance. Join researchers from University Hospitals Erlangen and Bionoveo as they share case studies on phenotype-based cell selection in T-cell manufacturing, including CD4:CD8 ratio control, and see how Sony Biotechnology's CGX10 Cell Isolation System supports next-generation T-cell therapy manufacturing.